


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed - 14 Jul 2011
GlaxoSmithKline and Human Genome Sciences Receive European Authorization for BENLYSTA(R) (Belimumab)
GlaxoSmithKline and Human Genome Sciences Receive European Authorization for BENLYSTA(R) (Belimumab)
HSMN NewsFeed - 8 Jul 2011
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
Amsterdam Molecular Therapeutics Files Glybera(R) European Marketing Application for Re-examination
HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
HSMN NewsFeed - 13 Jun 2011
Gore Receives Health Canada Approval for GORE(R) SEAMGUARD(R) Bioabsorbable Staple Line Reinforcement
Gore Receives Health Canada Approval for GORE(R) SEAMGUARD(R) Bioabsorbable Staple Line Reinforcement
HSMN NewsFeed - 1 Jun 2011
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
